Partner Menu

Business Development & Technology Transfer

CSHL is engaged in technology transfer as one way of delivering important discoveries to the public. Our Office of Technology Transfer actively supports our scientists to partner with companies, investors and others in order to achieve this mission and make a positive impact on society.

Guiding Principles

The purpose of CSHL鈥檚 technology transfer activities is to enable the scientific research conducted by our faculty, scientific staff and students to be developed and applied for the common good.To achieve this goal, we follow these guiding principles:

  • Work collaboratively with CSHL scientists to support their aspirations, manage conflicts, comply with regulations and encourage synergy with CSHL鈥檚 mission
  • Support effective dissemination of technology and leverage intellectual property rights and resources
  • Encourage commercial opportunities with the potential to make a significant positive impact
  • Engage with industry and investors to find the best partners to move ideas forward
  • Negotiate fair and reasonable terms for deals that encourage commercialization, global access and good returns

Performance Metrics

The ultimate measure of our performance is the impact on society through our commercialization efforts. Early performance indicators include funds received, transactions entered into and relationships established and maintained.

about technology transfer

Business Development & Technology Transfer News

Technology Transfer Process

Our Scientist鈥檚 Guide outlines key elements of the technology transfer process at CSHL. Learn more.

Commercial Relations

Engagement with industry and commercial relationships are governed by CSHL鈥檚 Commercial Relations Policy. Learn more.

Technology Disclosure

If you are a CSHL scientist and think the results of your research have commercial potential, please come talk with us. We will discuss completing a Technology Disclosure Form and address any questions you have about our process. Learn more.

Material Transfer

The exchange of research materials is an essential part of scientific research. It promotes effective collaboration among CSHL scientists and their counterparts in academia, government and industry. Learn more.

Conflict of Interest Policy

The Investigator Conflict of Interest Policy sets forth specific procedures for annual disclosure and review of significant financial interests so that, as an institution, the highest standards of integrity and objectivity are applied to the design, conduct and reporting of research carried out at or by CSHL. Learn more.

Consulting

Consulting agreements are private contracts between investigators and companies outside the scope of CSHL employment. Investigators have an obligation to familiarize themselves with CSHL鈥檚 policies relevant to consulting activities before entering into any such arrangement. Learn more.

Faculty Guide

provides an introduction to the areas of research interest for each member of our faculty.

Licensing

CSHL鈥檚 world-renowned research programs span Cancer, Neuroscience, Plant Biology, Quantitative Biology and Bioinformatics & Genomics. CSHL鈥檚 research environment is highly collaborative, allowing CSHL scientists to work together across disciplines to solve biology鈥檚 most challenging problems, with the ultimate goal of benefiting the public by advancing this research to improve the diagnosis and treatment of cancer, neurological disorders and other diseases. With that goal in mind, CSHL grants licenses to existing and startup companies that demonstrate the technical and financial capabilities to develop our early-stage technology into commercially successful products. Companies are encouraged to discuss their business interests with our Office of Technology Transfer so we can bring the CSHL inventions and prominent investigators in their areas of interest to their attention. Learn more.

Material Transfer Agreements

The Office of Technology Transfer supports CSHL scientists with agreements to transfer proprietary materials into and out of CSHL through Material Transfer Agreements as well as tangible material licensing arrangements.

shRNA Technology Licenses

CSHL research has played a major role in developing short hairpin RNAs (shRNAs) as important biomedical research tools that we wish to see distributed and used broadly. Learn more.

Sponsored Research

CSHL鈥檚 preferred sponsored research arrangement with industry would follow our Uniform SRA format.

A scientist in a lab coat works with lab equipment; text reads Bioscience Business Innovation Program.

*Now Accepting Applications*

Applications are now open for the 2025/2026 Bioscience Business Innovation Program (BBIP)!
馃搮 Deadline to Apply is September 30th 2025.
See Below for application instructions, or visit

In partnership with Hofstra University鈥檚 Zarb School of Business, 黑料吃瓜资源鈥檚 Business Development and Technology Transfer Office has developed a unique program 鈥 a first-of-its-kind initiative that equips our PhD students and postdoctoral fellows with the entrepreneurial and business expertise needed to translate cutting-edge science into impactful innovations.

Through both online and in-person experiences, the program is an immersive foundations of business experience where graduate students, law students and fellow scientists all learn what鈥檚 required to bring a vision to market. 

The Bioscience Business Innovation Program reinforces CSHL鈥檚 mission to train the next generation of scientific leaders. By pairing world-class research training with entrepreneurial education, we prepare our students and fellows not only to make discoveries, but also to shepherd them into real-world applications.

Program at a Glance

  • Immersive hybrid learning: One week of hands-on sessions at Hofstra鈥檚 Zarb School of Business and one week of online, self-paced coursework.
  • Team-based innovation: In follow-up self-paced course-work, CSHL scientists collaborate with Hofstra MBA and law students to develop business plans and pitch ideas to venture capitalists and industry leaders.
  • From science to strategy: Topics include market validation, FDA regulatory pathways, biotech financing, bioethics, intellectual property, leadership, and team building.

The CSHL Advantage

This program is uniquely tailored for CSHL trainees:

  • Real-world commercialization skills that complement CSHL鈥檚 rigorous scientific training.
  • Exposure to industry networks including venture capital, biotech executives, and regulatory experts.
  • A bridge from research to impact, ensuring our discoveries move beyond the bench to benefit society.
A group of thirteen people pose together indoors on steps by a glass railing, smiling at the camera.
The 2024 Bioscience Business Innovation Program participants and leadership

Voices from Our Trainees
馃挰 鈥淭his program gave me a whole new perspective on how discoveries move from idea to product. The pitching sessions and trading room simulations were eye-opening.鈥 鈥 Eva Lentsch, MD/PhD Scientist

馃挰 鈥淚鈥檓 eager to explore opportunities beyond academia. This program showed me how the biotech sector works and helped me imagine where my skills fit in.鈥 鈥 Stephen Staklinski, PhD Student

馃挰 鈥淲orking alongside MBA and law students pushed us to think differently. We came away with skills and confidence to communicate science in a business context.鈥 鈥 CSHL Cohort Feedback

Learn More

The program is coordinated through Hofstra鈥檚 Institute of Innovation and Entrepreneurship, with faculty drawn from business, law, and biotech sectors. For more details on the program and application instructions, visit Hofstra鈥檚 Zarb School of Business program page .

How to Apply

  • Click Apply to the Program
  • Select Graduate Application
  • Select Graduate Non Matriculated Study
  • Under the Academic Interest tab, select BBIP
  • Complete the application form
  • Upload the required documents

馃搷Questions? Contact [email protected]

image of the cover of CSHL Scientists Guide

The Office of Technology Transfer is located in the Luke Building.

General contact information
Email: [email protected]
Phone: 516-367-8301

Andrew Whiteley
Vice President
Business Development & Technology Transfer
[email protected]

Betsy Panagot
Executive Assistant & Office Manager
[email protected]

Debra B. Arenare, J.D.
Vice President, General Counsel
[email protected]

Vladimir Drozdoff, Ph.D., J.D.
Chief Patent Counsel
[email protected]

Eric Greenbaum, J.D.
Director of New Ventures and AI
[email protected]

Elizabeth A. Hand
Database, Accounting & Compliance Manager
[email protected]

Cynthia R. Miller, J.D.
Transactions Associate
[email protected]

Radhakrishnan (鈥淩K鈥) Narayanan, Ph.D., M.B.A.
Senior Director
[email protected]